Health, Biotech & Nutrition R&D Companies UK

Crop Health and Protection (CHAP) is a UK-based innovation centre that acts as a catalyst for the agricultural technology sector, facilitating collaborative R&D between industry, academia, and farmers. They focus on accelerating the development and adoption of sustainable farming solutions, including precision agriculture, bio-protection, and controlled environment systems. Their work bridges the gap between fundamental research and commercial application to address food security, net zero targets, and resource efficiency in the UK food supply chain.

CIELIVESTOCK (Centre for Innovation Excellence in Livestock) operates a UK agri-tech centre coordinating collaborative R&D across the livestock supply chain, focusing on animal health, genetics, diagnostics, nutrition, and sustainability. The company facilitates consortia of academic, industry, and farming partners to address challenges in productivity, disease management, and environmental impact, evolving from broad centre operations to targeted projects in epigenomics, methane reduction, and precision farming.

The University of Leeds is a leading UK research institution that drives innovation across diverse sectors including energy, healthcare, food science, and infrastructure. Through extensive collaborative R&D, the university bridges the gap between fundamental academic research and industrial application, focusing on sustainability, circular economy principles, and advanced manufacturing. Their work has evolved from foundational scientific studies to complex, multi-stakeholder projects that address national and global challenges such as decarbonisation, food security, and regulatory reform.

The University of Lincoln is a research-intensive academic institution that acts as a primary hub for agri-tech innovation and industrial collaboration in the East Midlands. Their work spans the development of autonomous robotic systems, precision breeding, sustainable nutrient management, and digital transformation, often bridging the gap between fundamental research and commercial application through Knowledge Transfer Partnerships. Their R&D portfolio has evolved from general agricultural research to highly specialised, interdisciplinary projects integrating robotics, AI, and sustainable energy solutions for the food and drink sector.

Johnson & Johnson Services Inc is a global healthcare giant specialising in the development of advanced medical technologies, pharmaceuticals, and consumer health products. Their work focuses on integrating genomic data into clinical practice to improve patient outcomes and accelerate the diagnosis of complex conditions. Through large-scale research initiatives, they aim to bridge the gap between fundamental genomic science and practical, scalable healthcare solutions.

The University of Surrey is a leading UK research institution that bridges the gap between fundamental academic inquiry and industrial application. Their work spans diverse domains including advanced telecommunications, sustainable food systems, AI-driven data marketplaces, and aerospace manufacturing. By leveraging a broad network of industry partners, they translate complex scientific research into practical solutions for societal and economic challenges.

The University of Aberdeen is a research-intensive academic institution that leverages its expertise in biotechnology, data science, and engineering to solve complex industrial and societal challenges. Through a robust portfolio of Knowledge Transfer Partnerships and collaborative R&D, the university translates fundamental research into practical applications across sectors including healthcare, energy, and agriculture. Their work has evolved from traditional academic inquiry to a highly commercialised model of technology transfer, focusing on sustainability, digital transformation, and health innovation.

Scotland's Rural College (SRUC) is a leading academic and research institution specialising in agricultural science, veterinary medicine, and environmental sustainability. They bridge the gap between fundamental research and practical on-farm application, focusing on livestock health, soil biodiversity, and the transition of the UK agricultural sector toward Net Zero. Their work has evolved from traditional agricultural research to a highly collaborative, technology-driven approach that integrates AI, robotics, and circular economy principles into food production systems.

Genomics England is a government-owned company established to deliver the 100,000 Genomes Project and advance the clinical application of genomic medicine within the NHS. They develop large-scale data infrastructure and analytical frameworks to integrate whole genome sequencing into routine clinical care and cancer research. Their work focuses on bridging the gap between complex genomic data and actionable clinical insights for patient benefit.

Mologic is a diagnostics company specialising in point-of-care tests for infectious diseases, respiratory conditions, and animal health. They develop lateral flow assays, virus-like particle vaccines, and integrated digital diagnostic platforms, with a strong emphasis on affordable testing for global health and low-resource settings. Their work has evolved from stratified medicine projects for COPD and sepsis to large-scale global health initiatives in sub-Saharan Africa and, more recently, livestock diagnostics.

Autolus is a clinical-stage biopharmaceutical company specialising in the development of next-generation programmed T-cell therapies for the treatment of cancer. Their work focuses on engineering CAR T-cell products that target both liquid and solid tumours, while simultaneously addressing the complex manufacturing and supply chain challenges inherent in personalised medicine. Over their grant history, they have evolved from fundamental research into CAR T-cell mechanisms to leading large-scale industrial consortia focused on the digitalisation and standardisation of advanced therapy manufacturing processes.

Cellular Therapeutics is a biotechnology company specialising in the development of tumour-infiltrating lymphocyte (TIL) therapies for solid tumours, with a focus on manufacturing processes and clinical translation. Their work has evolved from early microfluidic cell processing tools to leading clinical trials of engineered TILs for ovarian cancer, supported by a strong network of academic, NHS, and industry partners.

Bactobio discovers novel antibiotics and fungicides from previously unculturable microbes using synthetic biology, next-generation sequencing, and machine learning. The company addresses antimicrobial resistance and crop diseases by accessing the 99% of microbes that cannot be cultured in the lab, screening for new bioactive compounds. Their work has evolved from targeted antibiotic discovery to broad high-throughput screening with AI integration.

Oxford Biomedica is a global leader in the development and manufacture of lentiviral vectors, providing essential platform technologies for cell and gene therapies. Their work spans the entire value chain from clinical development to commercial-scale GMP manufacturing, with a focus on integrating advanced robotics, digital frameworks, and process analytical technologies. The company has evolved from a pioneer in in vivo delivery to a large-scale manufacturer supporting major commercial products like Kymriah.

Arecor is a biotherapeutic formulation company specialising in developing stable formulations of therapeutic proteins, particularly for diabetes care. Their proprietary formulation technology enables improved stability and action profiles for insulin and glucagon, addressing unmet needs in glucose management. Their work has evolved from early proof-of-concept projects to clinical-stage products, including ultra-long acting, superfast acting, and ultra-rapid insulins, with a focus on enabling closed-loop artificial pancreas systems.